glp 1 regulation Science Behind GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements Clinical Focus on GLP-1 Agonists
Description
It reduces inflammation
20 In agreement with the ADA, the American Association of Clinical Endocrinologists (AACE) lists DPP-4 inhibitors as an alternative in patients with an A1C under 7.5% in whom the use of metformin is contraindicated
It is insurance against the nutritional gaps that GLP-1 appetite suppression creates, and it supports overall health during a period of significant metabolic change
& De Palma, C
Because gut inflammation is linked to many chronic diseases, this may be one of the mechanisms behind the broader health benefits researchers are seeing
